These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9652876)

  • 1. Nifedipine and cancer mortality: ten-year follow-up of 2607 patients after acute myocardial infarction.
    Jonas M; Goldbourt U; Boyko V; Mandelzweig L; Behar S; Reicher-Reiss H
    Cardiovasc Drugs Ther; 1998 May; 12(2):177-81. PubMed ID: 9652876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term mortality follow-up of hospital survivors of a myocardial infarction randomized to nifedipine in the SPRINT study. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
    Reicher-Reiss H; Behar S; Boyko V; Mandelzweig L; Kaplinsky E; Goldbourt U
    Cardiovasc Drugs Ther; 1998 May; 12(2):171-6. PubMed ID: 9652875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of cancer in postmyocardial infarction patients treated with short-acting nifedipine and diltiazem. Secondary Prevention Group.
    Kanamasa K; Kimura A; Miyataka M; Takenaka T; Ishikawa K
    Cancer; 1999 Mar; 85(6):1369-74. PubMed ID: 10189144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary prevention reinfarction Israeli nifedipine trial (SPRINT). A randomized intervention trial of nifedipine in patients with acute myocardial infarction. The Israeli Sprint Study Group.
    Eur Heart J; 1988 Apr; 9(4):354-64. PubMed ID: 2898363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Secondary Prevention Group.
    Ishikawa K; Nakai S; Takenaka T; Kanamasa K; Hama J; Ogawa I; Yamamoto T; Oyaizu M; Kimura A; Yamamoto K; Yabushita H; Katori R
    Circulation; 1997 May; 95(10):2368-73. PubMed ID: 9170398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin and mortality in survivors of acute myocardial infarction: observations in patients at low and intermediate risk. The SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
    Leor J; Goldbourt U; Behar S; Boyko V; Reicher-Reiss H; Kaplinsky E; Rabinowitz B
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):609-17. PubMed ID: 8547212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Benzafibrate Infarction Prevention (BIP) Study Research Group.
    Braun S; Boyko V; Behar S; Reicher-Reiss H; Laniado S; Kaplinsky E; Goldbourt U
    J Am Coll Cardiol; 1998 Mar; 31(4):804-8. PubMed ID: 9525550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of nifedipine in the treatment of hypertension, coronary heart disease and myocardial infarction (post-infarction therapy).
    Schulz J; Schmidt J; Rück W
    Curr Med Res Opin; 1996; 13(7):397-408. PubMed ID: 8862939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nifedipine after acute myocardial infarction--sola dosis facit venenum: only the dose determines the harm.
    Messerli FH
    Cardiovasc Drugs Ther; 1998 May; 12(2):149-50. PubMed ID: 9652872
    [No Abstract]   [Full Text] [Related]  

  • 10. Myocardial infarction. Secondary prevention with nifedipine.
    Rafflenbeul W; Ebner F
    Drugs; 1991; 42 Suppl 2():38-42. PubMed ID: 1718700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients.
    Kloner RA; Vetrovec GW; Materson BJ; Levenstein M
    Am J Cardiol; 1998 Jan; 81(2):163-9. PubMed ID: 9591899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium antagonists in secondary prevention after acute myocardial infarction: the Secondary Prevention Reinfarction Nifedipine Trial (SPRINT).
    Neufeld HN
    Eur Heart J; 1986 Jul; 7 Suppl B():51-2. PubMed ID: 3530769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study.
    Goldbourt U; Behar S; Reicher-Reiss H; Zion M; Mandelzweig L; Kaplinsky E
    Arch Intern Med; 1993 Feb; 153(3):345-53. PubMed ID: 8285927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long-acting versus short-acting calcium channel blockers among older survivors of acute myocardial infarction.
    Gillman MW; Ross-Degnan D; McLaughlin TJ; Gao X; Spiegelman D; Hertzmark E; Goldman L; Soumerai SB
    J Am Geriatr Soc; 1999 May; 47(5):512-7. PubMed ID: 10323641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke risk after anterior wall acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
    Tanne D; Reicher-Reiss H; Boyko V; Behar S
    Am J Cardiol; 1995 Oct; 76(11):825-6. PubMed ID: 7572664
    [No Abstract]   [Full Text] [Related]  

  • 16. [Myocardial infarction beyond the 48 first hours: treatment with calcium channel antagonists].
    Delahaye F; de Gevigney G; Ovize M; Landrivon G; Rabilloud M; André-Fouët X; Delaye J
    Arch Mal Coeur Vaiss; 1992 Nov; 85(11 Suppl):1717-24. PubMed ID: 1304145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel blockers and mortality in elderly patients with myocardial infarction.
    Jollis JG; Simpson RJ; Chowdhury MK; Cascio WE; Crouse JR; Massing MW; Smith SC
    Arch Intern Med; 1999 Oct; 159(19):2341-8. PubMed ID: 10547174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium channel blockers for hypertension: dissecting the evidence for adverse effects.
    Opie LH
    Am J Hypertens; 1997 May; 10(5 Pt 1):565-77. PubMed ID: 9160770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium channel blocker debate: true lies?
    Leor J; Battler A
    Cardiovasc Drugs Ther; 1996 Sep; 10(4):413-5. PubMed ID: 8924054
    [No Abstract]   [Full Text] [Related]  

  • 20. The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
    Disegni E; Goldbourt U; Reicher-Reiss H; Kaplinsky E; Zion M; Boyko V; Behar S
    J Clin Epidemiol; 1995 Oct; 48(10):1197-205. PubMed ID: 7561981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.